Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy: a Randomized Double-blind Placebo-controlled Study

NCT00371956 is registered in ClinicalTrials.gov with Tuen Mun Hospital as lead sponsor.

NCT NCT00371956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00371956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy: a Randomized Double-blind Placebo-controlled Study
Lead sponsor
Tuen Mun Hospital
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2006
Completion date
February 28, 2010
Enrollment
114 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis